ArticleOncotarget2016
MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.
Tetsu Tomonari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it
ArticleOncotarget2016
Tetsu Tomonari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.